02/19/2024
Great news to start off the week. We congratulate our industry partner, Iovance Biotherapeutics, for pursuing accelerated approval for this treatment.
SpeciCare and our Live Tissue Science provides our patients the opportunity for this and many other cutting-edge procedures that can mean the difference in your journey. Call us today to speak with a personal patient advocate. www.specicare.com
Iovance Biotherapeutics said on Friday the U.S. health regulator has granted an accelerated approval for its cell therapy for adult patients with advanced melanoma, the first such treatment to be approved for the deadliest form of skin cancer.